RemImazolam Besylate for ICU-sedation in Patients With Mechanical Ventilation After Oral and Maxillofacial Surgery

Clinical trial NCT05606315 · TERMINATED

Trial details

NCT number: NCT05606315
Sponsor: Nanfang Hospital, Southern Medical University
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Sedation ICU Remimazolam Besylate

Start date: 2022-03-16
Primary completion: 2025-01-12
Enrollment: 117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.